BE870548A - Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic - Google Patents

Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic

Info

Publication number
BE870548A
BE870548A BE190539A BE190539A BE870548A BE 870548 A BE870548 A BE 870548A BE 190539 A BE190539 A BE 190539A BE 190539 A BE190539 A BE 190539A BE 870548 A BE870548 A BE 870548A
Authority
BE
Belgium
Prior art keywords
cosmetic
pharmaceutical
preparation
new process
diagnosis forms
Prior art date
Application number
BE190539A
Other languages
English (en)
French (fr)
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of BE870548A publication Critical patent/BE870548A/xx

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat
    • F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
    • F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0283—Matrix particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/22—Gas releasing
    • A61K2800/222—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/524—Preservatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/652—The particulate/core comprising organic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Mechanical Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Drying Of Solid Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE190539A 1977-09-19 1978-09-18 Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic BE870548A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7728193A FR2403078A1 (fr) 1977-09-19 1977-09-19 Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic

Publications (1)

Publication Number Publication Date
BE870548A true BE870548A (fr) 1979-03-19

Family

ID=9195532

Family Applications (1)

Application Number Title Priority Date Filing Date
BE190539A BE870548A (fr) 1977-09-19 1978-09-18 Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic

Country Status (15)

Country Link
US (1) US4178695A (ja)
JP (1) JPS5495720A (ja)
BE (1) BE870548A (ja)
CA (1) CA1097209A (ja)
CH (1) CH633445A5 (ja)
DE (1) DE2840461A1 (ja)
DK (1) DK154528C (ja)
ES (1) ES473459A1 (ja)
FR (1) FR2403078A1 (ja)
GB (1) GB2004182B (ja)
IE (1) IE47020B1 (ja)
IT (1) IT1106901B (ja)
LU (1) LU80251A1 (ja)
NL (1) NL186675C (ja)
SE (1) SE444645B (ja)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1209477A (en) * 1981-03-26 1986-08-12 Bruce E. Haeger Composition of matter comprising a lyophilized preparation of a penicillin derivative
US4429542A (en) * 1981-08-10 1984-02-07 Hoxan Corporation Method of freezing fertilized ova, spermatozoa or the like and apparatus therefor
JPS58154547A (ja) * 1982-03-09 1983-09-14 Nippon Shinyaku Co Ltd アズレン誘導体の安定化法
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
FR2539626B2 (fr) * 1983-01-25 1985-06-21 Lafon Labor Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede
US4642903A (en) * 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
US4712310A (en) * 1986-09-15 1987-12-15 E. I. Du Pont De Nemours And Company Co-spray technique
IL86892A (en) * 1987-07-08 1993-04-04 Lafon Labor Filter comprising a material obtained by freeze-drying, its preparation and its use, especially in pharmacy
JP2865320B2 (ja) * 1989-08-07 1999-03-08 株式会社資生堂 固型化粧料組成物
FR2670675B1 (fr) * 1990-12-20 1993-04-16 Lafon Labor Procede de preparation de formes pharmaceutiques stables a base d'acide acetylsalicylique ou de ses sels.
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
FR2702968B1 (fr) * 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
US8236352B2 (en) 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
US6316029B1 (en) 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
EP1353695A2 (en) * 2001-01-26 2003-10-22 Schering Corporation Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
PT1355644E (pt) * 2001-01-26 2006-11-30 Schering Corp Utilização de compostos azetidinona substituídos para o tratamento de sitosterolemia
IL156585A0 (en) * 2001-01-26 2004-01-04 Schering Corp Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
RS20100015A (sr) * 2001-01-26 2010-12-31 Schering Corporation Kombinacija aktivatora receptora aktiviranog peroksizom- proliferatorom (ppar) fenofibrata sa inhibitorom apsorpcije sterola ezetimibom za vaskularne indikacije
ATE369851T1 (de) * 2001-01-26 2007-09-15 Schering Corp Kombinationen von gallensäuresequestriermitteln und hemmern der sterolabsorption zur behandlung von kardiovaskulären indikationen
IL156488A0 (en) * 2001-01-26 2004-01-04 Schering Corp Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
DE60216275T2 (de) * 2001-05-25 2007-06-21 Schering Corp. Verwendung von mit azetidinon substituierten derivaten bei der behandlung der alzheimer-krankheit
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
EP1429756B1 (en) * 2001-09-21 2006-11-22 Schering Corporation Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
CN101785772A (zh) * 2001-09-21 2010-07-28 先灵公司 使用甾醇吸收抑制剂治疗或预防脉管炎的方法
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
DE60222160T2 (de) * 2001-10-12 2008-06-12 Elan Pharma International Ltd., Athlone Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung
EP1487419A2 (en) * 2002-03-20 2004-12-22 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability
JP2006508188A (ja) * 2002-11-06 2006-03-09 シェーリング　コーポレイション 脱髄の処置のためのコレステロール吸収インヒビター
CN1756756A (zh) 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
CN1756755A (zh) * 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
DE602004016123D1 (de) 2003-03-07 2008-10-09 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
JP2007501683A (ja) * 2003-05-22 2007-02-01 エラン ファーマ インターナショナル リミテッド γ線照射によるナノ粒子活性物質分散体の滅菌法
JP2007510659A (ja) * 2003-11-05 2007-04-26 シェーリング　コーポレイション 脂質調節剤および置換アゼチジノンの組み合わせならびに血管状態の処置
BRPI0507113A (pt) * 2004-01-28 2007-06-19 Unilever Nv corpos porosos, método para preparar corpos porosos, e, soluções ou dispersões
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
EP1870649A1 (en) 2006-06-20 2007-12-26 Octapharma AG Lyophilisation targetting defined residual moisture by limited desorption energy levels
US20090238867A1 (en) * 2007-12-13 2009-09-24 Scott Jenkins Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
FR2945950A1 (fr) 2009-05-27 2010-12-03 Elan Pharma Int Ltd Compositions de nanoparticules anticancereuses et procedes pour les preparer
MX2022013043A (es) 2020-04-16 2023-01-24 Tavanta Therapeutics Hungary Incorporated Metodos y composiciones para tratar el cancer de prostata.
CN114532542A (zh) * 2022-02-24 2022-05-27 山东坦途农业科技有限公司 一种夹心冻干赋型制剂及其制备方法
FR3160664B1 (fr) 2024-03-27 2026-02-13 Stellantis Auto Sas Structure avant de véhicule automobile et véhicule automobile comportant une telle structure avant

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2984992A (en) * 1954-07-28 1961-05-23 Union Carbide Corp Apparatus for freeze dehydration of liquid bearing solids
US3309779A (en) * 1966-02-02 1967-03-21 Fmc Corp Dehydration of solids-bearing liquids
GB1190319A (en) * 1968-08-15 1970-05-06 George Jarvis Tooby Method for Dehydrating Materials
DE1900995A1 (de) * 1969-01-09 1970-08-27 Struthers Scient And Internat Gefriertrocknungsverfahren fuer Nahrungsmittel und dabei erhaltene Produkte
FR2036890B1 (ja) * 1969-04-15 1973-01-12 Orsymonde
NL6915749A (en) * 1969-10-17 1971-04-20 Powdered products from fruit and vegetable juices aqs - vegetable extracts such as coffee, tea, etc having porous
FR2068447A1 (en) * 1969-11-26 1971-08-27 Orsymonde Dehydrated pharmaceutical comps by - lyophilisation
US3673698A (en) * 1970-11-25 1972-07-04 Albert S Guerard Process for freeze drying with carbon dioxide
JPS503381A (ja) * 1973-05-11 1975-01-14
JPS506532A (ja) * 1973-05-22 1975-01-23

Also Published As

Publication number Publication date
IE781341L (en) 1979-03-19
IT1106901B (it) 1985-11-18
ES473459A1 (es) 1979-10-16
IT7851099A0 (it) 1978-09-15
DK333678A (da) 1979-03-20
CA1097209A (en) 1981-03-10
JPS5495720A (en) 1979-07-28
DK154528B (da) 1988-11-21
IE47020B1 (en) 1983-11-30
NL186675C (nl) 1991-02-01
LU80251A1 (fr) 1979-03-07
JPS62884B2 (ja) 1987-01-10
CH633445A5 (fr) 1982-12-15
GB2004182B (en) 1982-03-24
DK154528C (da) 1989-04-10
NL7809522A (nl) 1979-03-21
FR2403078A1 (fr) 1979-04-13
SE7808007L (sv) 1979-03-20
US4178695A (en) 1979-12-18
DE2840461A1 (de) 1979-03-29
SE444645B (sv) 1986-04-28
DE2840461C2 (ja) 1988-10-06
GB2004182A (en) 1979-03-28
FR2403078B1 (ja) 1981-07-03
NL186675B (nl) 1990-09-03

Similar Documents

Publication Publication Date Title
IT7851099A0 (it) Procedimento per produrre forme farmaceutiche cosmetiche o di diagnostica
NL188078C (nl) Farmaceutisch preparaat voor de behandeling van hartarrhytmieen en myocardiale aandoeningen.
IT1160900B (it) Procedimento per la preparazione di dispersioni dei composti di cerio
NL7803166A (nl) Nieuwe oximverbindingen van 3-acetoxymethyl- -7-amino-thiazolylaceetamidocefalosporaanzuur, werkwijze voor hun bereiding en onder toepassing daarvan verkregen geneesmiddelen.
NL7701849A (nl) Werkwijze voor de bereiding van geneesmiddelen onder toepassing van pyrethrinoiden.
BE873136A (fr) Procede de preparation de la vincadifformine
NL7812643A (nl) N-gesubstitueerde omega-aminoalkanoyl omega-aminoalkaancarbonzuren, toepassing van deze verbindingen, werkwijze ter bereiding van deze verbindingen, benevens geneesmiddelen, die deze verbindingen bevatten.
NL7811251A (nl) Werkwijze voor de bereiding van tereftaalzuur.
MX6053E (es) Procedimiento microbiologico para la preparacion de derivados del sesquiterpeno
BE864030Q (fr) Agent de diagnostic pour la recherche de la bilirubine
NL190119C (nl) Werkwijze voor de bereiding van 4-hydroxy-5-alkyl- en 4-hydroxy-2,5-dialkyl-3-oxo-2h-furanen.
NL7802848A (nl) Werkwijze voor de bereiding en toepassing van gesubstitueerde bisbenzimidazolylverbindingen.
NL187907C (nl) Werkwijze voor de bereiding van fenylglyoxylzuuresters.
LU80272A1 (fr) Procede de preparation d'agents therapeutiques antiallergiques
NL7800001A (nl) Werkwijze voor de bereiding van nieuwe chromoon- derivaten en de toepassing hiervan als genees- middel tegen hartziekten.
LU78854A1 (fr) Procede de preparation d'une composition antimicrobienne de nettoyage de la peau
NL7801158A (nl) Werkwijze voor de bereiding van cyclohexaan- derivaten.
BE866662A (fr) Procede de preparation de 3,5-dihalogenanilines
NL7605189A (nl) Werkwijze ter bereiding van geneesmiddelen die 3,5-bisgeoxygeneerde 2-(omega-halogeen-3-geoxy- geneerde-1-alkenyl)-cyclopentaan-1-heptaanzuren en derivaten daarvan bevatten, alsmede de vol- gens deze werkwijze verkregen gevormde preparaten.
NL7812567A (nl) Werkwijze voor de bereiding van menselijke chorionso- matomammotropine.
NL188037B (nl) Werkwijze voor de bereiding van dl-fenylglycine-amide via racemisatie.
NL7800067A (nl) Werkwijze voor de bereiding van een farmaceu- tisch preparaat.
NL7803559A (nl) Thiobenzylpyrimidine, werkwijze voor de bereiding hier- van en de toepassing van deze stof als geneesmiddel.
PT67885A (fr) Procede de preparation de nouvelles compositions pharmaceutiques destinees notammentau traitement des troubles fonctionnels cerebraux.
BE871068A (fr) Nouveau procede de preparation de 4-chloroquinoleines

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: LABORATOIRE L. LAFON

Effective date: 19980918